WHO Refers to GM Mosquitoes as Beneficial TechnologyOctober 21, 2020
The World Health Organization (WHO) released its official statement to clarify its stance on the evaluation and use of genetically modified (GM) mosquitoes and its use to control vector-borne diseases (VBD). WHO says it supports the investigation of all potentially beneficial technologies, and these include GM mosquitoes.
The position statement has seven key points:
- WHO recognizes the major impact of VBD has made on the global community. Though efforts have been made to control them, the progress stalled in recent years. Thus, it is important to urgently develop and test new tools to control the pathogens and vectors.
- New technologies, including GM mosquitoes, are recognized by the WHO as a supplement or alternative to existing interventions to help further reduce or prevent disease transmission. The organization takes the position that all potentially beneficial new technologies should be investigated to determine how useful they are in the continued fight against diseases of public health concern.
- Current national and institutional mechanisms of governance and oversight must be adapted to the purpose rather than replaced.
- Evaluation should be done using established and internationally-recognized risk assessment tools and procedures, and the decisions arising from these evaluations should account for the potential health benefits in consideration of disease control, and not be limited to potential environmental risk.
- WHO recognizes that community engagement is essential in developing effective approaches to fight against VBDs when planning and conducting field trials prior to the introduction of any new public health intervention. WHO states that these public engagements are a priority in field research of GM mosquitoes.
Read the full position statement by WHO to find out more.
You might also like:
- Scientists Engineer Mosquitoes to Repel Dengue Virus
- Florida Board Allows First GM Mosquito Trials in the US
- U.S. EPA Grants Approval to Conduct GE Mosquito Field Trials
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
- International Team of Scientists Identify Common Vulnerabilities in COVID-19 and Other Lethal Coronaviruses
- COVID-19 Virus Can Survive 28 Days on Surfaces
News from Around the World
- WHO Refers to GM Mosquitoes as Beneficial Technology
- Scientists Use Glowing Venus Flytraps to Understand Its Closure Mechanism
- Pamela Ronald is 2020 World Agriculture Prize Laureate
- Pinkglow™, Del Monte's Pink Pineapple Now Available
- Indian Farmer Confirms Socio-economic Impact of Bt Cotton
- Biotech Experts to Tackle Global Impact of GM Crops
- EFSA Study Concludes Maize MON810 Poses No Risk to Humans, Animals, or the Environment
- Researchers Pinpoint Peanut Genes Linked to Salt and Drought Tolerance
Plant Breeding Innovations
- New Tool to Accelerate Crop Improvement with CRISPR
- New Genome Editing Tool Designed to Make Big DNA Edits
Read the latest:
- Crop Biotech Update (August 17, 2022)
- Genome Editing Supplement (August 10, 2022)
- Gene Drive Supplement (July 27, 2022)
Subscribe to CBU: